EP1177207A4 - Adn codant pour le gene de type antigene membranaire specifique de la prostate et utilisations de celui-ci - Google Patents

Adn codant pour le gene de type antigene membranaire specifique de la prostate et utilisations de celui-ci

Info

Publication number
EP1177207A4
EP1177207A4 EP00921932A EP00921932A EP1177207A4 EP 1177207 A4 EP1177207 A4 EP 1177207A4 EP 00921932 A EP00921932 A EP 00921932A EP 00921932 A EP00921932 A EP 00921932A EP 1177207 A4 EP1177207 A4 EP 1177207A4
Authority
EP
European Patent Office
Prior art keywords
dna encoding
prostate specific
type gene
specific membrane
membrane antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP00921932A
Other languages
German (de)
English (en)
Other versions
EP1177207A1 (fr
Inventor
Warren D W Heston
Denise S O'keefe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Memorial Sloan Kettering Cancer Center
Original Assignee
Memorial Sloan Kettering Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Memorial Sloan Kettering Cancer Center filed Critical Memorial Sloan Kettering Cancer Center
Publication of EP1177207A1 publication Critical patent/EP1177207A1/fr
Publication of EP1177207A4 publication Critical patent/EP1177207A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EP00921932A 1999-04-09 2000-04-07 Adn codant pour le gene de type antigene membranaire specifique de la prostate et utilisations de celui-ci Withdrawn EP1177207A4 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12883999P 1999-04-09 1999-04-09
US128839P 1999-04-09
PCT/US2000/009417 WO2000061605A1 (fr) 1999-04-09 2000-04-07 Adn codant pour le gene de type antigene membranaire specifique de la prostate et utilisations de celui-ci

Publications (2)

Publication Number Publication Date
EP1177207A1 EP1177207A1 (fr) 2002-02-06
EP1177207A4 true EP1177207A4 (fr) 2003-06-04

Family

ID=22437235

Family Applications (1)

Application Number Title Priority Date Filing Date
EP00921932A Withdrawn EP1177207A4 (fr) 1999-04-09 2000-04-07 Adn codant pour le gene de type antigene membranaire specifique de la prostate et utilisations de celui-ci

Country Status (4)

Country Link
EP (1) EP1177207A4 (fr)
AU (1) AU774697B2 (fr)
CA (1) CA2370033A1 (fr)
WO (1) WO2000061605A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5355839B2 (ja) 2001-10-23 2013-11-27 ピーエスエムエー デベロプメント カンパニー， エル．エル．シー． Ｐｓｍａ抗体およびタンパク質マルチマー
US20050215472A1 (en) 2001-10-23 2005-09-29 Psma Development Company, Llc PSMA formulations and uses thereof
CA2469623C (fr) 2001-12-12 2012-05-29 F H Faulding & Co Limited Composition pour la conservation de virus
WO2006028429A2 (fr) * 2002-08-05 2006-03-16 The Johns Hopkins University Peptide pour cibler l'antigene prostatique membranaire specifique
WO2006013014A2 (fr) * 2004-08-04 2006-02-09 Bayer Healthcare Ag Diagnostics et therapeutiques pour maladies liees a une proteine similaire a un antigene membranaire specifique de la prostate (psmal)
EP2326350B1 (fr) 2008-09-08 2013-09-04 Psma Development Company, L.L.C. Composés pour tuer des cellules cancéreuses exprimant psma et résistantes au taxane
US8709400B2 (en) 2009-07-27 2014-04-29 Washington University Inducement of organogenetic tolerance for pancreatic xenotransplant

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026272A1 (fr) * 1995-02-24 1996-08-29 Sloan-Kettering Institute For Cancer Research Antigene membranaire specifique de la prostate et ses utilisations

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69334071T2 (de) * 1992-11-05 2007-10-25 Sloan-Kettering Institute For Cancer Research Prostata-spezifisches membranantigen

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996026272A1 (fr) * 1995-02-24 1996-08-29 Sloan-Kettering Institute For Cancer Research Antigene membranaire specifique de la prostate et ses utilisations

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
O'KEEFE D S ET AL: "Identification and characterization of a new member of the prostate-specific membrane antigen gene family.", PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH ANNUAL, vol. 40, March 1999 (1999-03-01), 90th Annual Meeting of the American Association for Cancer Research;Philadelphia, Pennsylvania, USA; April 10-14, 1999, March, 1999, pages 482, XP001147724, ISSN: 0197-016X *
O'KEEFE D S ET AL: "MAPPING, GENOMIC ORGANIZATION AND PROMOTER ANALYSIS OF THE HUMAN PROSTATE-SPECIFIC MEMBRANE ANTIGEN GENE", BIOCHIMICA ET BIOPHYSICA ACTA, AMSTERDAM, NL, vol. 1443, no. 1/2, November 1998 (1998-11-01), pages 113 - 127, XP001023046, ISSN: 0006-3002 *
See also references of WO0061605A1 *

Also Published As

Publication number Publication date
EP1177207A1 (fr) 2002-02-06
AU4218900A (en) 2000-11-14
WO2000061605A1 (fr) 2000-10-19
AU774697B2 (en) 2004-07-01
CA2370033A1 (fr) 2000-10-19

Similar Documents

Publication Publication Date Title
AU4313701A (en) Nucleic acids, proteins, and antibodies
AU2440102A (en) Nucleic acid ligands to the prostate specific membrane antigen
AU5077101A (en) Nucleic acids, proteins, and antibodies
MXPA03002328A (es) Polipeptidos y acidos nucleicos de receptor novedoso.
EP1131333A4 (fr) Molecules d'acide nucleique isolees codant pour des facteurs inductibles derives de lymphocytes t (tif), proteines codees et leur utilisation
ZA983148B (en) Modified TNFÓ, DNA encoding such modified TNFÓ and vacines comprising said TNFÓ and DNA.
AU4903101A (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
DK1082423T3 (da) Cyclin E2-gener og -proteiner
EP1177207A4 (fr) Adn codant pour le gene de type antigene membranaire specifique de la prostate et utilisations de celui-ci
AU2001296301A8 (en) Nucleic acids, proteins, and antibodies
MXPA03004700A (es) Metodos y celulas para detectar moduladores de proteinas rgs.
WO2003025134A3 (fr) Acides nucleiques codant la mcfp, polypeptides mcfp, anticorps mcfp et leurs procedes d'utilisation
AU1174402A (en) Nucleic acid molecules and polypeptides for immune modulation
AU3095801A (en) Nucleic acids, proteins, and antibodies
HUP0300813A3 (en) Genes and proteins, and their uses
AU2001227570A1 (en) Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof
EP1235837A4 (fr) Polynucleotides, polypeptides et anticorps renfermant des domaines kringle
EP1174503A4 (fr) Nouvelles proteines, gene les codant et leur procede d'utilisation
MXPA03005428A (es) Nuevas proteinas y moleculas de acido nucleico moduladoras del receptor de glutamato y uso de las mismas.
AU9227301A (en) Novel proteins, genes encoding them and method of using the same
AU2001241414A8 (en) Nucleic acids, proteins, and antibodies
WO2001098459A3 (fr) Acides nucleiques codant hei-c, polypeptides hei-c, anticorps hei-c et leurs methodes d'utilisation
GB9726575D0 (en) Nucleic acid, polypeptides, assays, therapeutic methods and means
AU4905401A (en) Nucleic acids, proteins, and antibodies
AU5516201A (en) Nucleic acids, proteins, and antibodies

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20011006

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

AX Request for extension of the european patent

Free format text: AL;LT;LV;MK;RO;SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030425

17Q First examination report despatched

Effective date: 20031126

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20060825